Lovastatin Tablet
Product Images NDC 68071-3622

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 68071-3622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lovastatin (65abb8c3 847f 4fb3 B8de 21888c01210b 01)

Chemical structure of lovastatin, showing its molecular configuration including rings, hydroxyl group, carbonyl groups, and methyl substituents as depicted in the diagram.*

FDA Label Image

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over years of follow-up. Two curves are compared: one for Lovastatin and one for Placebo, indicating a 37% risk reduction with Lovastatin (p < 0.0001) over approximately 6 years.*

FDA Label Image

Pdp (68071 3622 1)

Label for Lovastatin 10 mg tablets by NuCare Pharmaceuticals, Inc. The label states a package quantity of 100 tablets, with the product manufactured by Lupin Limited Goa, India. Includes NDC 68071-3622-1, instructions to see manufacturer's label for ingredients, storage temperature guidance, and a warning to keep out of reach of children. The label also notes the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.